GfK no longer operates as an independent company. Following its 2023 acquisition by NIQ Group — the parent company of NielsenIQ — the GfK brand has been integrated into NIQ's global structure. For companies and organisations in Egypt looking for an independent international market research alternative, BioNixus operates a dedicated regional office in Cairo, serving healthcare, pharmaceutical, consumer health, and multiple other industries across Egypt and the wider MENA region since 2012.
GfK Is Now Part of NIQ Group. GfK — Gesellschaft für Konsum-, Markt- und Absatzforschung — was one of the world's largest market research organisations, founded in Germany in 1934. For decades, GfK operated independently across consumer intelligence, market measurement, technology tracking, and media research in markets including Egypt and the wider MENA region.
In 2023, GfK was fully acquired by NIQ Group, the parent company of NielsenIQ. The acquisition combined two major consumer intelligence businesses under a single ownership structure. As a result, GfK no longer operates as an independent company anywhere in the world — including Egypt. GfK's brand, client relationships, products, and operations are being progressively consolidated into the NIQ Group structure under the NielsenIQ identity.
What This Means for GfK Clients in Egypt: Companies that previously commissioned research through GfK now deal with NIQ (NielsenIQ) as the successor entity. NIQ's Egypt operations are primarily focused on fast-moving consumer goods (FMCG) tracking, retail measurement, and consumer panel data. The specialist research services that GfK offered beyond FMCG — including healthcare, pharmaceutical, technology durables, and custom qualitative research — may no longer be available at the same depth through the combined NIQ entity in Egypt.
For organisations that need an independent, international market research agency in Egypt — one that is not solely focused on FMCG retail tracking — BioNixus provides a specialist alternative with a dedicated Cairo office and established research infrastructure across all Egyptian governorates.
Many international market research agencies claim Egypt coverage but deliver it through subcontracted local fieldwork agencies. BioNixus operates a dedicated regional office in Cairo — the MENA hub for all BioNixus operations across Egypt, Saudi Arabia, UAE, Kuwait, Qatar, Bahrain, and Oman. Your research is managed by BioNixus directly: the same quality standards, project management approach, and data governance that you would expect from an international agency — executed in-market by people who live and work in Egypt.
BioNixus has been conducting market research in Egypt since 2012. Over twelve years we have built physician panels, consumer recruitment networks, hospital data relationships, and qualitative moderator capability across Cairo, Alexandria, the Delta, and Upper Egypt governorates. This depth of local knowledge cannot be replicated by a global firm that subcontracts Egypt fieldwork on a project-by-project basis.
While BioNixus is best known for healthcare and pharmaceutical market research, the Cairo office serves clients across multiple industries operating in Egypt. The research skills that make BioNixus effective in pharmaceutical research — rigorous sample design, verified respondent panels, Arabic-language instrument development, and governorate-level field reach — translate directly to consumer health, OTC products, medical devices, food and nutrition, health insurance, and public health programme evaluation.
BioNixus project management is headquartered in London and the United States, bringing international client service standards, GDPR-compliant data handling, and ICH-GCP compliant fieldwork protocols to every Egypt study. Clients based in Europe or North America commission Egypt research through BioNixus exactly as they would commission a UK or US study — same proposal format, same reporting templates, same quality assurance process.
BioNixus's Cairo team conducts research in Arabic as a native capability — not a translated afterthought. Questionnaires are developed in Arabic from the outset, discussion guides are written by native-Arabic moderators, and CATI fieldwork is conducted by Arabic-speaking interviewers who understand Egyptian dialect, cultural sensitivities, and the social dynamics that affect response quality in Egyptian research settings.
Physician surveys across all specialties. Hospital sales data from pharmacy dispensing, MOH procurement, and physician data at patient, indication, department, and hospital level. KOL mapping. Market access covering EDA registration and HIA reimbursement.
Egypt is the largest medical devices market in Africa. Physician perception studies, hospital procurement research, competitive positioning, and clinical decision-maker interviews across public and private hospital settings.
Consumer surveys, brand awareness studies, usage and attitude research, and retail pharmacy consumer intercepts across Cairo, Alexandria, and provincial cities for OTC pharmaceutical, supplement, and consumer health brands.
Attitude and usage studies, new product concept testing, brand tracking, and segmentation research among Egyptian consumers across socioeconomic groups and geographic regions.
Egypt's Universal Health Insurance (UHI) programme is reshaping the pharmaceutical market. Beneficiary surveys, provider network research, and payer decision-maker interviews for the evolving UHI landscape.
Health system assessments, patient surveys, community health worker studies, and programme evaluation for international NGOs and development organisations — particularly outside Cairo in Upper Egypt and underserved communities.
Egypt is the most populous Arab country and the largest pharmaceutical market in Africa, with over 105 million people and 250,000+ registered physicians. Market research in Egypt that relies solely on Cairo samples systematically misrepresents the national picture.
Key Egypt Healthcare Institutions BioNixus Works With:
Egyptian Drug Authority (EDA) and Regulatory Context: The EDA (formerly CAPA) regulates pharmaceutical product registration and clinical research in Egypt. The Health Insurance Authority (HIA) governs reimbursement under the Universal Health Insurance programme. BioNixus's market access research covers both the EDA registration pathway and the evolving HIA reimbursement landscape.
| Capability | BioNixus | GfK / NIQ Egypt |
|---|---|---|
| Independent agency status | ✓ Fully independent | ✗ GfK absorbed into NIQ Group (2023) |
| Dedicated Cairo office | ✓ Regional MENA headquarters | ~ NielsenIQ Egypt office (FMCG focus) |
| Healthcare and pharma research | ✓ Core specialism — physicians, hospitals, patients | ✗ Not NIQ/GfK's focus in Egypt |
| Physician survey panels — Egypt | ✓ Verified against EDA and MOHP databases | ✗ Not available |
| Hospital sales data — Egypt | ✓ Pharmacy, procurement, physician-sourced | ✗ Not available |
| Consumer health and OTC research | ✓ Consumer surveys, brand tracking, pharmacy intercepts | ~ FMCG panel available through NIQ |
| Upper Egypt and governorate coverage | ✓ All governorates including rural Upper Egypt | ~ Primarily urban centres |
| Arabic-language fieldwork | ✓ Native Egyptian Arabic capability | ✓ Available |
| Qualitative research — Egypt | ✓ Focus groups, IDIs, Arabic moderators | ~ Limited healthcare qualitative |
| MENA multi-country studies | ✓ Egypt + 6 GCC countries, single vendor | ~ Available through NIQ global network |
| ICH-GCP compliant fieldwork | ✓ Standard for all healthcare studies | ~ Case by case |
| Contract model | Project-based, no minimum | Enterprise and subscription |
GfK no longer operates as an independent market research company in Egypt or globally. In 2023, GfK was fully acquired by NIQ Group — the parent company of NielsenIQ — and the GfK brand is being integrated into the NIQ entity. Clients in Egypt who previously worked with GfK are now directed to NIQ (NielsenIQ). For an independent international market research alternative with a dedicated Cairo office, BioNixus has been operating in Egypt since 2012.
GfK was acquired by NIQ Group — the parent company of NielsenIQ — in 2023. The acquisition merged two of the world's largest consumer intelligence and market measurement firms. GfK's brand, operations, and client relationships are being progressively integrated into the NIQ Group structure. GfK as an independent company with standalone Egypt operations no longer exists.
BioNixus is a leading international market research alternative in Egypt, operating a dedicated regional office in Cairo since 2012. BioNixus serves multiple industries — healthcare, pharmaceutical, medical devices, consumer health, food and nutrition, health insurance, and NGOs — delivering quantitative surveys, qualitative research, brand tracking, physician panels, hospital data, and competitive intelligence in Arabic and English across all Egyptian governorates. Contact: admin@bionixus.com | UK: +44 7727 666682 | US: +1 888 465 5557.
International market research companies with a physical presence in Egypt include BioNixus (Cairo regional office, multiple industries including healthcare, pharma, and consumer health), NielsenIQ/NIQ (FMCG and consumer goods), and Ipsos Egypt (consumer and opinion research). BioNixus is the only specialist firm combining international methodology standards with direct healthcare and multi-industry coverage across all Egyptian governorates including Upper Egypt.
Yes. BioNixus delivers quantitative surveys, consumer perception studies, brand tracking, competitive landscape analysis, qualitative focus groups and depth interviews, and market sizing across Egypt — the core research types GfK was known for. BioNixus additionally specialises in healthcare and pharmaceutical research capabilities that GfK did not offer as a core product, making BioNixus a more comprehensive Egypt market research partner for companies in health-adjacent industries.
Yes. BioNixus serves multiple industries through its Cairo office: consumer health and OTC products, medical devices and MedTech, food and nutrition, health insurance and managed care, NGOs and international development, government public health programmes, and corporate research for multinationals with Egyptian operations — alongside its core healthcare and pharmaceutical specialism.
BioNixus operates a regional office in Cairo, Egypt, which serves as the MENA headquarters for operations across Egypt, Saudi Arabia, UAE, Kuwait, Qatar, Bahrain, and Oman. The Cairo office manages field operations, physician and consumer panels, and qualitative recruitment across all Egyptian governorates — from Cairo and Giza through Alexandria, Mansoura, Assiut, Luxor, Aswan, and Upper Egypt. BioNixus also has offices in London (UK) and Sheridan, Wyoming (USA).
BioNixus provides research scopes and budget estimates within 48 hours. Whether you need a physician survey, a consumer study, a qualitative programme, or a multi-country MENA project anchored in Egypt — our Cairo team is ready.
Request a Scope →